The DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
Lipid-Based Nanoparticles for Drug/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in Their Industrial Development
Open accessAbstract
Over the past decade, the therapeutic potential of nanomaterials as novel drug delivery systems complementing conventional pharmacology has been widely acknowledged. Among these nanomaterials, lipid-based nanoparticles (LNPs) have shown remarkable pharmacological performance and promising therapeutic outcomes, thus gaining substantial interest in preclinical and clinical research. In this review, we introduce the main types of LNPs used in drug formulations such as liposomes, nanoemulsions, solid lipid nanoparticles, nanostructured lipid carriers, and lipid polymer hybrid nanoparticles, focusing on their main physicochemical properties and therapeutic potential. We discuss computational studies and modeling techniques to enhance the understanding of how LNPs interact with therapeutic cargo and to predict the potential effectiveness of such interactions in therapeutic applications. We also analyze the benefits and drawbacks of various LNP production techniques such as nanoprecipitation, emulsification, evaporation, thin film hydration, microfluidic-based methods, and an impingement jet mixer. Additionally, we discuss the major challenges associated with industrial development, including stability and sterilization, storage, regulatory compliance, reproducibility, and quality control. Overcoming these challenges and facilitating regulatory compliance represent the key steps toward LNP's successful commercialization and translation into clinical settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119
Self-citationDoxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
Lipid nanoparticles for mRNA delivery
Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Advances and Challenges of Liposome Assisted Drug Delivery
Sercombe, L., Veerati, T., Moheimani, F., Wu, S. Y., Sood, A. K., & Hua, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00286 · Cited by 2,632
Toxicity of cationic lipids and cationic polymers in gene delivery
Lv, H., Zhang, S., Wang, B., Cui, S., & Yan, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.014 · Cited by 2,286
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
(1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.10.1329 · Cited by 2,192
Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., & O'Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,153
Formation and stability of nano-emulsions
Tadros, T., Izquierdo, P., Esquena, J., & Solans, C. (2004) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2003.10.023 · Cited by 2,001
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Polymer-based nanocapsules for drug delivery
Mora-Huertas, C. E., Fessi, H., & Elaissari, A. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.018 · Cited by 1,742
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Akinc, A., Maier, M. A., Manoharan, M., Fitzgerald, K., Jayaraman, M., Barros, S., Ansell, S., Du, X., Hope, M. J., Madden, T. D., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0591-y · Cited by 1,636
Nanoemulsions: Formation, properties and applications
Gupta, A., Eral, H. B., Hatton, T. A., & Doyle, P. S. (2016) · Soft Matter · doi:10.1039/c5sm02958a · Cited by 1,633
mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability
Schoenmaker, L., Witzigmann, D., Kulkarni, J. A., Verbeke, R., Kersten, G., Jiskoot, W., & Crommelin, D. J. A. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120586 · Cited by 1,566
Gabizón, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., & Barenholz, Y. (1994) · PubMed · Cited by 1,382
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205
Nanoemulsion: an advanced mode of drug delivery system
Jaiswal, M., Dudhe, R., & Sharma, P. K. (2015) · 3 Biotech · doi:10.1007/s13205-014-0214-0 · Cited by 1,203
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069
Nanoparticle-Based Sustainable Agriculture and Food Science: Recent Advances and Future Outlook
Mittal, D., Kaur, G., Singh, P., Yadav, K., & Ali, S. A. (2020) · Frontiers in Nanotechnology · doi:10.3389/fnano.2020.579954 · Cited by 788
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
Beloqui, A., Solinís, M. Á., Rodríguez-Gascón, A., Almeida, A. J., & Préat, V. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.09.004 · Cited by 769
Liposomes: Advancements and innovation in the manufacturing process
Shah, S., Dhawan, V., Holm, R., Nagarsenker, M. S., & Perrie, Y. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.002 · Cited by 745
Nanoprecipitation process: From encapsulation to drug delivery
Martínez Rivas, C. J., Tarhini, M., Badri, W., Miladi, K., Greige-Gerges, H., Nazari, Q. A., Galindo Rodríguez, S. A., Román, R. Á., Fessi, H., & Elaissari, A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.08.064 · Cited by 733
Surfactants Used in Food Industry: A Review
Kralova, I., & Sjöblom, J. (2009) · Journal of Dispersion Science and Technology · doi:10.1080/01932690902735561 · Cited by 725
The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery
Cheng, X., & Lee, R. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.022 · Cited by 703
Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review
Hadinoto, K., Sundaresan, A., & Cheow, W. S. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.07.002 · Cited by 702
Microfluidic technologies for accelerating the clinical translation of nanoparticles
Valencia, P. M., Farokhzad, O. C., Karnik, R., & Langer, R. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.168 · Cited by 698
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
Scioli Montoto, S., Muraca, G., & Ruiz, M. E. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.587997 · Cited by 652
A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems
Duan, Y., Dhar, A., Patel, C., Khimani, M., Neogi, S., Sharma, P., Siva Kumar, N., & Vekariya, R. L. (2020) · RSC Advances · doi:10.1039/d0ra03491f · Cited by 614
Nucleoside analogues and nucleobases in cancer treatment
Galmarini, C. M., Mackey, J. R., & Dumontet, C. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00788-x · Cited by 606
Stimuli‐responsive liposomes for drug delivery
Lee, Y., & Thompson, D. H. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1450 · Cited by 579
Foulkes, R., Man, E., Thind, J., Yeung, S., Joy, A., & Hoskins, C. (2020) · Biomaterials Science · doi:10.1039/d0bm00558d · Cited by 568
Lipid Nanoparticles for Drug Delivery
Xu, L., Wang, X., Liu, Y., Yang, G., Falconer, R. J., & Zhao, C.-X. (2022) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100109 · Cited by 545
Stone, N. R. H., Bicanic, T., Salim, R., & Hope, W. (2016) · Drugs · doi:10.1007/s40265-016-0538-7 · Cited by 537
Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery
Chauhan, I., Yasir, M., Verma, M., & Singh, A. P. (2020) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2020.021 · Cited by 518
Kim, J., Eygeris, Y., Gupta, M., & Sahay, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.014 · Cited by 514
nab-Paclitaxel mechanisms of action and delivery
Yardley, D. A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.05.041 · Cited by 508
Nanoemulsions and Their Potential Applications in Food Industry
Aswathanarayan, J. B., & Vittal, R. R. (2019) · Frontiers in Sustainable Food Systems · doi:10.3389/fsufs.2019.00095 · Cited by 502
Chanan-Khan, A., Szebeni, J., Savay, S., Liebes, L., Rafique, N. M., Alving, C. R., & Muggia, F. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg374 · Cited by 479
Zeta potential: a case study of cationic, anionic, and neutral liposomes
Smith, M. C., Crist, R. M., Clogston, J. D., & McNeil, S. E. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-017-0527-z · Cited by 479
Uziely, B., Jeffers, S., Isacson, R., Kutsch, K., Wei-Tsao, D., Yehoshua, Z., Libson, E., Muggia, F. M., & Gabizon, A. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1777 · Cited by 477
Size and surface charge characterization of nanoparticles with a salt gradient
Rasmussen, M. K., Pedersen, J. N., & Marie, R. (2020) · Nature Communications · doi:10.1038/s41467-020-15889-3 · Cited by 468
Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier
Salvi, V. R., & Pawar, P. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.02.017 · Cited by 456
Preparation of solid lipid nanoparticles by a solvent emulsification–diffusion technique
Trotta, M., Debernardi, F., & Caputo, O. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00135-2 · Cited by 439
Intranasal nanoemulsion based brain targeting drug delivery system of risperidone
Kumar, M., Misra, A., Babbar, A. K., Mishra, A. K., Mishra, P., & Pathak, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.03.029 · Cited by 435
Liposome Technology for Industrial Purposes
Wagner, A., & Vorauer-Uhl, K. (2011) · Journal of Drug Delivery · doi:10.1155/2011/591325 · Cited by 435
Ganesan, P., & Narayanasamy, D. (2017) · Sustainable Chemistry and Pharmacy · doi:10.1016/j.scp.2017.07.002 · Cited by 434
Microfluidic formulation of nanoparticles for biomedical applications
Shepherd, S. J., Issadore, D., & Mitchell, M. J. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120826 · Cited by 433
Crystallization tendency and polymorphic transitions in triglyceride nanoparticles
Bunjes, H., Westesen, K., & Koch, M. H. J. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04286-5 · Cited by 425
Amphotericin B: time for a new “gold standard”
Saravolatz, L. D., Ostrosky-Zeichner, L., Marr, K. A., Rex, J. H., & Cohen, S. H. (2003) · Clinical Infectious Diseases · doi:10.1086/376634 · Cited by 406
Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery
Battaglia, L., & Gallarate, M. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.673278 · Cited by 400
Lipid Formulations of Amphotericin B: Clinical Efficacy and Toxicities
Wong-Beringer, A., Jacobs, R. A., & Guglielmo, B. J. (1998) · Clinical Infectious Diseases · doi:10.1086/514704 · Cited by 395
Geszke-Moritz, M., & Moritz, M. (2016) · Materials Science and Engineering: C · doi:10.1016/j.msec.2016.05.119 · Cited by 392
Nanostructured lipid carriers and their current application in targeted drug delivery
Jaiswal, P., Gidwani, B., & Vyas, A. (2014) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2014.909822 · Cited by 372
Nanoemulsions for drug delivery
Wilson, R. J., Li, Y., Yang, G., & Zhao, C.-X. (2022) · Particuology · doi:10.1016/j.partic.2021.05.009 · Cited by 367
A comprehensive review on recent preparation techniques of liposomes
Has, C., & Sunthar, P. (2020) · Journal of Liposome Research · doi:10.1080/08982104.2019.1668010 · Cited by 357
Oxygen Radical-Mediated Pulmonary Toxicity Induced by Some Cationic Liposomes
Dokka, S., Toledo, D., Shi, X., Castranova, V., & Rojanasakul, Y. (2000) · Pharmaceutical Research · doi:10.1023/a:1007504613351 · Cited by 349 · cited 1×
“197,198 Similarly, LNPs containing YSK05, a pH-sensitive cationic lipid used for delivering short interfering RNA (siRNA), exhibited rapid interactions with cell surfaces, leading to concentration-dependent toxicity in human A375 and A375-SM melanoma cell lines.”
BackgroundMicrofluidic technologies and devices for lipid nanoparticle-based RNA delivery
Maeki, M., Uno, S., Niwa, A., Okada, Y., & Tokeshi, M. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.017 · Cited by 349
Ball, R., Bajaj, P., & Whitehead, K. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s123062 · Cited by 333
Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics
Roces, C. B., Lou, G., Jain, N., Abraham, S., Thomas, A., Halbert, G. W., & Perrie, Y. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111095 · Cited by 321
Maeki, M., Kimura, N., Sato, Y., Harashima, H., & Tokeshi, M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.03.008 · Cited by 319
Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device
Shepherd, S. J., Warzecha, C. C., Yadavali, S., El-Mayta, R., Alameh, M.-G., Wang, L., Weissman, D., Wilson, J. M., Issadore, D., & Mitchell, M. J. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c01353 · Cited by 317
Eleven years of Inflexal® V—a virosomal adjuvanted influenza vaccine
Herzog, C., Hartmann, K., Künzi, V., Kürsteiner, O., Mischler, R., Lazar, H., & Glück, R. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.029 · Cited by 292
Harashima, H., Sakata, K., Funato, K., & Kiwada, H. (1994) · Pharmaceutical Research · doi:10.1023/a:1018965121222 · Cited by 284
Microfluidic Nanoparticles for Drug Delivery
Liu, Y., Yang, G., Hui, Y., Ranaweera, S., & Zhao, C. (2022) · Small · doi:10.1002/smll.202106580 · Cited by 277
Autio, K. A., Dreicer, R., Anderson, J., Garcia, J. A., Alva, A., Hart, L. L., Milowsky, M. I., Posadas, E. M., Ryan, C. J., Graf, R. P., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.2168 · Cited by 275
Das, S., Ng, W. K., Kanaujia, P., Kim, S., & Tan, R. B. H. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.07.036 · Cited by 274
A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems
Packer, M., Gyawali, D., Yerabolu, R., Schariter, J., & White, P. (2021) · Nature Communications · doi:10.1038/s41467-021-26926-0 · Cited by 273
Cosmetic features and applications of lipid nanoparticles (SLN®, NLC®)
Souto, E. B., & Müller, R. H. (2008) · International Journal of Cosmetic Science · doi:10.1111/j.1468-2494.2008.00433.x · Cited by 268
Drug delivery and drug targeting with parenteral lipid nanoemulsions — A review
Hörmann, K., & Zimmer, A. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.016 · Cited by 264
Quercetin-nanostructured lipid carriers: Characteristics and anti-breast cancer activities in vitro
Sun, M., Nie, S., Pan, X., Zhang, R., Fan, Z., & Wang, S. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2013.08.032 · Cited by 263
Review on the Scale-Up Methods for the Preparation of Solid Lipid Nanoparticles
Khairnar, S. V., Pagare, P., Thakre, A., Nambiar, A. R., Junnuthula, V., Abraham, M. C., Kolimi, P., Nyavanandi, D., & Dyawanapelly, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091886 · Cited by 263
Berger, N., Sachse, A., Bender, J., Schubert, R., & Brandl, M. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00721-9 · Cited by 258
Long-term storage of lipid-like nanoparticles for mRNA delivery
Zhao, P., Hou, X., Yan, J., Du, S., Xue, Y., Li, W., Xiang, G., & Dong, Y. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.03.001 · Cited by 233
Epaxal®: a virosomal vaccine to prevent hepatitis A infection
Bovier, P. A. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.8.1141 · Cited by 233
Application of flash nanoprecipitation to fabricate poorly water-soluble drug nanoparticles
Tao, J., Chow, S. F., & Zheng, Y. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.11.001 · Cited by 232
AFM, ESEM, TEM, and CLSM in liposomal characterization: a comparative study
Ruozi, B., Belletti, D., Tombesi, A., Tosi, G., Bondioli, L., Forni, F., & Vandelli, M. A. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s14615 · Cited by 225
MOF nanoparticles coated by lipid bilayers and their uptake by cancer cells
Wuttke, S., Braig, S., Preiß, T., Zimpel, A., Sicklinger, J., Bellomo, C., Rädler, J. O., Vollmar, A. M., & Bein, T. (2015) · Chemical Communications · doi:10.1039/c5cc06767g · Cited by 223
Solid lipid nanoparticles as vehicles of drugs to the brain: Current state of the art
Gastaldi, L., Battaglia, L., Peira, E., Chirio, D., Muntoni, E., Solazzi, I., Gallarate, M., & Dosio, F. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.05.004 · Cited by 222
Molecular and Mesoscale Simulation Methods for Polymer Materials
Glotzer, S. C., & Paul, W. (2002) · Annual Review of Materials Research · doi:10.1146/annurev.matsci.32.010802.112213 · Cited by 218
Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles
Siekmann, B., & Westesen, K. (1994) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/0927-7765(94)80063-4 · Cited by 217
Sjöström, B., & Bergenståhl, B. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90303-j · Cited by 215
LUZZATI, V., TARDIEU, A., & GULIK-KRZYWICKI, T. (1968) · Nature · doi:10.1038/2171028a0 · Cited by 214
Multi‐Functional Liposome: A Powerful Theranostic Nano‐Platform Enhancing Photodynamic Therapy
Cheng, X., Gao, J., Ding, Y., Lu, Y., Wei, Q., Cui, D., Fan, J., Li, X., Zhu, E., Lu, Y., et al. (2021) · Advanced Science · doi:10.1002/advs.202100876 · Cited by 208
Beck, H., Härter, M., Haß, B., Schmeck, C., & Baerfacker, L. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.02.015 · Cited by 198
O'Brien, S., Schiller, G., Lister, J., Damon, L., Goldberg, S., Aulitzky, W., Ben-Yehuda, D., Stock, W., Coutre, S., Douer, D., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.2309 · Cited by 196
Influence of surfactant and processing conditions in the stability of oil-in-water nanoemulsions
Silva, H. D., Cerqueira, M. A., & Vicente, A. A. (2015) · Journal of Food Engineering · doi:10.1016/j.jfoodeng.2015.07.037 · Cited by 190
Chen, M., Liu, X., & Fahr, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.006 · Cited by 183
Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications
Mazzarino, L., Travelet, C., Ortega-Murillo, S., Otsuka, I., Pignot-Paintrand, I., Lemos-Senna, E., & Borsali, R. (2012) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2011.12.063 · Cited by 177
Freeze-drying of live virus vaccines: A review
Hansen, L. J. J., Daoussi, R., Vervaet, C., Remon, J.-P., & De Beer, T. R. M. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.08.085 · Cited by 176
Membrane‐destabilizing ionizable lipid empowered imaging‐guided siRNA delivery and cancer treatment
Guo, S., Li, K., Hu, B., Li, C., Zhang, M., Hussain, A., Wang, X., Cheng, Q., Yang, F., Ge, K., et al. (2021) · Exploration · doi:10.1002/exp.20210008 · Cited by 175
Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies
Schiffelers, R. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.3.333 · Cited by 163
Vetten, M. A., Yah, C. S., Singh, T., & Gulumian, M. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.03.017 · Cited by 163
Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines
Kim, B., Hosn, R. R., Remba, T. K., Yun, D. S., Li, N., Abraham, W. D., Melo, M. B., Cortés, M., Li, B., Zhang, Y., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.11.022 · Cited by 163
Tumor-Vasculature-on-a-Chip for Investigating Nanoparticle Extravasation and Tumor Accumulation
Wang, H.-F., Ran, R., Liu, Y., Hui, Y., Zeng, B., Chen, D., Weitz, D. A., & Zhao, C.-X. (2018) · ACS Nano · doi:10.1021/acsnano.8b06846 · Cited by 161
Regulating Nanomedicine – Can the FDA Handle It?
Bawa, R. (2011) · Current Drug Delivery · doi:10.2174/156720111795256156 · Cited by 160
Cyclosporine A loaded SLNs: Evaluation of cellular uptake and corneal cytotoxicity
Gokce, E. H., Sandri, G., Bonferoni, M. C., Rossi, S., Ferrari, F., Güneri, T., & Caramella, C. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.028 · Cited by 159
Synthesis and Potential Applications of Lipid Nanoparticles in Medicine
Musielak, E., Feliczak-Guzik, A., & Nowak, I. (2022) · Materials · doi:10.3390/ma15020682 · Cited by 159
LIPID–POLYMER HYBRID NANOPARTICLES: SYNTHESIS, CHARACTERIZATION AND APPLICATIONS
Zhang, L., & Zhang, L. (2010) · Nano LIFE · doi:10.1142/s179398441000016x · Cited by 156
Cirri, M., Maestrini, L., Maestrelli, F., Mennini, N., Mura, P., Ghelardini, C., & Mannelli, L. D. C. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1529209 · Cited by 148
Forbes, N., Hussain, M. T., Briuglia, M. L., Edwards, D., ter Horst, J. H., Szita, N., & Perrie, Y. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.11.060 · Cited by 148
Lipid-Based Nanocarrier System for the Effective Delivery of Nutraceuticals
Subramanian, P. (2021) · Molecules · doi:10.3390/molecules26185510 · Cited by 143
In Vivo Sustained Release of siRNA from Solid Lipid Nanoparticles
Lobovkina, T., Jacobson, G. B., González-González, E., Hickerson, R. P., Leake, D., Kaspar, R. L., Contag, C. H., & Zare, R. N. (2011) · ACS Nano · doi:10.1021/nn203745n · Cited by 142
Ortiz, A. C., Yáñez, O., Salas‐Huenuleo, E., & Morales, J. O. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040531 · Cited by 135
Emulsions containing partially water-miscible solvents for the preparation of drug nanosuspensions
Trotta, M., Gallarate, M., Pattarino, F., et al. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00432-1 · Cited by 132
Targeted liposomes for combined delivery of artesunate and temozolomide to resistant glioblastoma
Ismail, M., Yang, W., Li, Y., Chai, T., Zhang, D., Du, Q., Muhammad, P., Hanif, S., Zheng, M., & Shi, B. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121608 · Cited by 131
Large-scale droplet production in microfluidic devices—an industrial perspective
Holtze, C. (2013) · Journal of Physics D Applied Physics · doi:10.1088/0022-3727/46/11/114008 · Cited by 129
Kuo, Y., & Liang, C.-T. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.048 · Cited by 125
Production & stability of stavudine solid lipid nanoparticles—From lab to industrial scale
Shegokar, R., Singh, K. K., & Müller, R. H. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.08.014 · Cited by 124
The history of cyclosporin A (Sandimmune®) revisited: Another point of view
Stähelin, H. (1996) · Cellular and Molecular Life Sciences · doi:10.1007/bf01922409 · Cited by 120
Let’s talk about lipid nanoparticles
(2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00281-4 · Cited by 119 · cited 1×
“10,217 Ensuring regulatory compliance for LNPs is paramount to guarantee their safety and effectiveness in therapeutic applications.”
BackgroundCationic Liposomes for Direct Gene Transfer in Therapy of Cancer and Other Diseasesa
Farhood, H., Gao, X., Son, K. K., et al. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21701.x · Cited by 119
Ding, S., Anton, N., Vandamme, T., & Serra, C. A. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1193151 · Cited by 119
Kuo, Y., & Chung, J.-F. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.11.037 · Cited by 116
Current Developments and Challenges of mRNA Vaccines
Chen, J., Chen, J., & Xu, Q. (2022) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-110220-031722 · Cited by 115
Kimura, N., Maeki, M., Sato, Y., Ishida, A., Tani, H., Harashima, H., & Tokeshi, M. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c05489 · Cited by 109
Computer-Assisted Drug Formulation Design: Novel Approach in Drug Delivery
Metwally, A. A., & Hathout, R. M. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500740d · Cited by 108
Baby, T., Liu, Y., Middelberg, A. P. J., & Zhao, C. (2017) · Chemical Engineering Science · doi:10.1016/j.ces.2017.04.046 · Cited by 108
Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery
Katara, R., & MAJUMDAR, D. K. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.10.056 · Cited by 107
Multiphase microfluidic synthesis of micro- and nanostructures for pharmaceutical applications
Ran, R., Sun, Q., Baby, T., Wibowo, D., Middelberg, A. P. J., & Zhao, C. (2017) · Chemical Engineering Science · doi:10.1016/j.ces.2017.01.008 · Cited by 107
Clemons, K. V., & Stevens, D. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.4.899 · Cited by 105
Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery
Ammar, H. O., Ha, S., Ghorab, M., & Mahmoud, A. A. K. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639041003801885 · Cited by 104
Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles
Venishetty, V. K., Komuravelli, R., Kuncha, M., Sistla, R., & Diwan, P. V. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.03.003 · Cited by 104
Hood, R. R., DeVoe, D. L., Atencia, J., Vreeland, W. N., & Omiatek, D. M. (2014) · Lab on a Chip · doi:10.1039/c4lc00334a · Cited by 102
Smiatek, J., Jung, A., & Bluhmki, E. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.05.008 · Cited by 100
Hathout, R. M., & Metwally, A. A. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.07.019 · Cited by 94
Microemulsions for oral administration and their therapeutic applications
Gibaud, S., & Attivi, D. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.694865 · Cited by 93
Adedoyin, A. B., Bernardo, J. F., Swenson, C. E., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2201 · Cited by 92
Siqueira-Moura, M. P., Primo, F. L., Espreáfico, E. M., & Tedesco, A. C. (2013) · Materials Science and Engineering C · doi:10.1016/j.msec.2012.12.088 · Cited by 91
Parchekani, J., Allahverdi, A., Taghdir, M., & Naderi‐Manesh, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-06380-8 · Cited by 90
Dong, Y., Ng, W. K., Shen, S., Kim, S., & Tan, R. B. H. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.01.018 · Cited by 83
Regulatory Considerations Specific to Liposome Drug Development as Complex Drug Products
Wang, Y., & Grainger, D. W. (2022) · Frontiers in Drug Delivery · doi:10.3389/fddev.2022.901281 · Cited by 83
El-Salamouni, N. S., Farid, R. M., El-Kamel, A. H., & El-Gamal, S. S. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.10.043 · Cited by 81
Soares, S. S., Fonte, P., Costa, A., Andrade, J. C., Seabra, V., Ferreira, D., Reis, S., & Sarmento, B. F. C. C. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.08.076 · Cited by 79
Araújo, V. H. S., Filippo, L. D. D., Duarte, J. L., Spósito, L., de Camargo, B. A. F., da Silva, P. B., & Chorilli, M. (2020) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1843399 · Cited by 77
Wang, Z., Cui, K., Costabel, U., & Zhang, X. (2022) · Exploration · doi:10.1002/exp.20210082 · Cited by 77
Microfluidic manufacturing improves polydispersity of multicomponent polymeric nanoparticles
Abstiens, K., & Göpferich, A. M. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.12.009 · Cited by 75
Lehtinen, J., Magarkar, A., Stȩpniewski, M., Hakola, S., Bergman, M., Róg, T., Yliperttula, M. L., Urtti, A. O., & Bunker, A. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.02.009 · Cited by 72
A New Vaccine to Battle Covid-19
Haynes, B. F. (2020) · New England Journal of Medicine · doi:10.1056/nejme2035557 · Cited by 71
Róg, T., Girych, M., & Bunker, A. (2021) · Pharmaceuticals · doi:10.3390/ph14101062 · Cited by 70
The tiny big world of solid lipid nanoparticles and nanostructured lipid carriers: an updated review
Abdel-Mageed, H. M., Aziz, A. E. A. E., Mohamed, S. A., & AbuelEzz, N. Z. (2021) · Journal of Microencapsulation · doi:10.1080/02652048.2021.2021307 · Cited by 69
Streck, S., Neumann, H., Nielsen, H. M., Rades, T., & McDowell, A. (2019) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2019.100030 · Cited by 66
Mechanism of transient dyspnea induced by pegylated-liposomal doxorubicin (Doxil???)
Skubitz, K. M., & Skubitz, A. P. N. (1998) · Anti-Cancer Drugs · doi:10.1097/00001813-199801000-00005 · Cited by 65
Jämbeck, J. P. M., Eriksson, E. S. E., Laaksonen, A., Lyubartsev, A. P., & Eriksson, L. A. (2013) · Journal of Chemical Theory and Computation · doi:10.1021/ct400466m · Cited by 62
Advanced packaging for distribution and storage of COVID-19 vaccines: a review
Ramakanth, D., Singh, S., Maji, P. K., Lee, Y. S., & Gaikwad, K. K. (2021) · Environmental Chemistry Letters · doi:10.1007/s10311-021-01256-1 · Cited by 60
PEGylated Liposomes as Carriers of Hydrophobic Porphyrins
Dzieciuch-Rojek, M., Rissanen, S., Szydłowska, N., Bunker, A., Kumorek, M., Jamróz, D., Vattulainen, I., Nowakowska, M., Róg, T., & Kępczyński, M. (2015) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b01351 · Cited by 59
Badawi, N. M., El‐Say, K. M., Attia, D. A., El-Nabarawi, M. A., Elmazar, M. M., & Teaima, M. H. M. (2020) · ACS Omega · doi:10.1021/acsomega.0c02618 · Cited by 59
Mass production system for RNA-loaded lipid nanoparticles using piling up microfluidic devices
Maeki, M., Okada, Y., Uno, S., Sugiura, K., Suzuki, Y., Okuda, K., Sato, Y., Ando, M., Yamazaki, H., Takeuchi, M., et al. (2023) · Applied Materials Today · doi:10.1016/j.apmt.2023.101754 · Cited by 59
Morphological Behavior of Liposomes and Lipid Nanoparticles
Zhigaltsev, I. V., & Cullis, P. R. (2023) · Langmuir · doi:10.1021/acs.langmuir.2c02794 · Cited by 58
Jakubek, Z. J., Chen, S., Zaifman, J., Tam, Y. Y. C., & Zou, S. (2023) · Langmuir · doi:10.1021/acs.langmuir.2c02657 · Cited by 56
Polchi, A., Magini, A., Mazuryk, J., Tancini, B., Gapiński, J., Patkowski, A., Giovagnoli, S., & Emiliani, C. (2016) · Nanomaterials · doi:10.3390/nano6050087 · Cited by 49
Kumar, G., Chaudhary, K., Mogha, N. K., Kant, A., & Masram, D. T. (2021) · ACS Omega · doi:10.1021/acsomega.1c02422 · Cited by 48
Chan, C., Du, S., Dong, Y., & Cheng, X. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666201126162945 · Cited by 46
Gupta, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816662-8.00021-7 · Cited by 45
Shafique, M. S., Rehman, M. U., Kamal, Z., Alzhrani, R. M., Alshehri, S., Alamri, A. H., Bakkari, M. A., Sabei, F. Y., Safhi, A. Y., Mohammed, A. M., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1025013 · Cited by 45
Kumar, G., Kant, A., Kumar, M., & Masram, D. T. (2019) · Inorganica Chimica Acta · doi:10.1016/j.ica.2019.119036 · Cited by 44
Carvajal-Vidal, P., Fábrega, M.-J., Espina, M., Calpena, A. C., & García, M. L. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102026 · Cited by 42
Lemaalem, M., Hadrioui, N., Derouiche, A., & Ridouane, H. (2020) · RSC Advances · doi:10.1039/c9ra08632c · Cited by 38
Venkatakrishnan, K., Liu, Y., Noe, D. A., Mertz, J., Bargfrede, M., Marbury, T. C., Farbakhsh, K., Oliva, C., & Milton, A. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12260 · Cited by 35
Characterization of Nanoscale Loaded Liposomes Produced by 2D Hydrodynamic Flow Focusing
Amrani, S., & Tabrizian, M. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00572 · Cited by 34
Bakshi, P., Jiang, Y., Nakata, T., Akaki, J., Matsuoka, N., & Banga, A. K. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.07.015 · Cited by 34
Izza, N., Suga, K., Okamoto, Y., Watanabe, N. M., Bui, T. T., Wibisono, Y., Fadila, C. R., & Umakoshi, H. (2021) · Langmuir · doi:10.1021/acs.langmuir.1c00270 · Cited by 33
Self-citationPreparing Amorphous Hydrophobic Drug Nanoparticles by Nanoporous Membrane Extrusion
Guo, P., Hsu, T. M., Zhao, Y., Martin, C. R., & Zare, R. N. (2012) · Nanomedicine · doi:10.2217/nnm.12.119 · Cited by 32
Distribution of Neutral Lipids in the Lipid Droplet Core
Chaban, V. V., & Khandelia, H. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp506693d · Cited by 32
Beyond traditional pharmacology: new tools and approaches
Gurevich, E. V., & Gurevich, V. V. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13066 · Cited by 31
Lipid Structure in Triolein Lipid Droplets
Chaban, V. V., & Khandelia, H. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp503223z · Cited by 31
Carvajal-Vidal, P., González-Pizarro, R., Araya, C., Espina, M., Halbaut, L., de Aranda, I. G., García, M. L., & Calpena, A. C. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119480 · Cited by 31
Venkatakrishnan, K., Liu, Y., Noe, D. A., Mertz, J., Bargfrede, M., Marbury, T. C., Farbakhsh, K., Oliva, C., & Milton, A. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12261 · Cited by 31
Ma, G. J., Yoon, B. K., Sut, T. N., Yoo, K. Y., Lee, S. H., Jeon, W., Jackman, J. A., Ariga, K., & Cho, N. (2021) · Open Research (University of Surrey) · doi:10.1002/viw.20200078 · Cited by 29
Song, S. Y., Kim, K., Jeong, S., Park, J. H., Park, J., Jung, J., Chung, H. K., Lee, S.-W., Seo, M. H., Lee, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12668 · Cited by 28
Pyrhönen, J., Bansal, K. K., Bhadane, R. N., Wilén, C., Salo‐Ahen, O. M. H., & Rosenholm, J. M. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100072 · Cited by 22
Balouch, M., Storchmannová, K., Štĕpánek, F., & Berka, K. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c01078 · Cited by 17
Handbook of Clinical Nanomedicine
Bawa, R., Audette, G. F., & Reese, B. (2016) · doi:10.1201/b19910 · Cited by 15
FDA approves DaunoXome as first-line therapy for Kaposi's sarcoma. Food and Drug Administration.
(1996) · PubMed · Cited by 14
Teucrium polium extract‐loaded solid lipid nanoparticles: A design and in vitro anticancer study
Roumi, S., Tabrizi, M. H., Es‐haghi, A., & Abbasi, N. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13868 · Cited by 13
Ikeuchi-Takahashi, Y., Kobayashi, A., Ishihara, C., Matsubara, T., Matsubara, H., & Onishi, H. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00964 · Cited by 9
Formulation and pharmacokinetic evaluation of rifampicin solid lipid nanoparticles
Gardouh, A. R., GAMAL, A., & Gad, S. (2020) · Journal of Research in Pharmacy · doi:10.35333/jrp.2020.202 · Cited by 7
Ahn, G. Y., Choi, I., Ryu, Y., Ryu, Y.-H., Oh, D.-H., Kang, M., Kang, M.-H., & Choi, S. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113212 · Cited by 6
AlBaloul, A. Y., Sato, Y., Maishi, N., Hida, K., & Harashima, H. (2019) · BPB Reports · doi:10.1248/bpbreports.2.4_48 · Cited by 4
FDA Fast Track Designation for Myocet for Metastatic Breast Cancer
(2010) · Oncology Times · doi:10.1097/01.cot.0000368457.66658.a6 · Cited by 4
General anesthetics and therapeutic gases
Hall, A., & Leuwer, M. (2011) · Side effects of drugs annual · doi:10.1016/b978-0-444-53741-6.00010-6 · Cited by 2
Cited by
Desai, N., Rana, D., Patel, M., Bajwa, N., Prasad, R., & Vora, L. K. (2025) · Small · doi:10.1002/smll.202502315 · Cited by 295
The landscape of nanoparticle-based siRNA delivery and therapeutic development
Moazzam, M., Zhang, M., Hussain, A., Yu, X., Huang, J., & Huang, Y. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.01.005 · Cited by 230
Syahputra, E. W., Lee, H., Cho, H., Park, H. J., Park, K.-S., & Hwang, D. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17040501 · Cited by 88
Ding, L., Kshirsagar, P., Agrawal, P., & Murry, D. J. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17060706 · Cited by 62
Tanaka, M., Araujo, A. C., Valenti, V. E., Guiguer, E. L., Catharin, V. C. S., Gualhardi, C. M., de Souza Bastos Mazuqueli Pereira, E., de Alvares Goulart, R., de Argolo Haber, R. S., de Carvalho, A. C. A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052370 · Cited by 13
Metadata
- Authors
- Mehta, M., Bui, T. A., Yang, X., Aksoy, Y., Goldys, E. M., & Deng, W.
- Venue
- ACS Materials Au
- Publisher
- American Chemical Society (ACS)
- Published
- 2023-08-21
- Volume
- 3
- Issue
- 6
- Pages
- 600-619
- ISSN
- 2694-2461 (ISSN-L)
- OpenAlex
- W4386030674
- Cited by
- 688
- References
- 184
- FWCI
- 37.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.